Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -92.07% is 1049% below its 3-year average of -8.01%, near the high end of its 3-year range (-416.49%–19.50%).
25.90% below its 12-month average of -73.13%.
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2026 (2026-06-30): 19.50%.
EBITDA MARGIN
-92.07%
EBITDA MARGIN AVG TTM
-73.13%
EBITDA MARGIN AVG 3Y
-8.01%
EBITDA MARGIN AVG 5Y
N/A
EBITDA MARGIN AVG 10Y
N/A
EBITDA MARGIN AVG 15Y
N/A
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-25.90%
CURRENT VS 3Y AVG
-1048.92%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Hinge Health, Inc.
Market Cap
$7.56B
EBITDA Margin
-92.07%
TTM Avg
-73.13%
3Y Avg
-8.01%
5Y Avg
N/A
Market Cap
$8.02B
EBITDA Margin
-3.14%
TTM Avg
-1.08%
3Y Avg
-5.02%
5Y Avg
-19.32%
Market Cap
$6.63B
EBITDA Margin
15.93%
TTM Avg
16.80%
3Y Avg
17.55%
5Y Avg
18.41%
Market Cap
$6.47B
EBITDA Margin
6.82%
TTM Avg
6.08%
3Y Avg
-0.44%
5Y Avg
-8.67%
Market Cap
$5.61B
EBITDA Margin
-395.82%
TTM Avg
-536.17%
3Y Avg
-471.62%
5Y Avg
-471.62%
Market Cap
$5.35B
EBITDA Margin
-15636.44%
TTM Avg
-8457.23%
3Y Avg
-41454.98%
5Y Avg
-35632.55%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Hinge Health, Inc. (HNGE) | $7.56B | -92.07% | -73.13% | -8.01% | N/A |
| Oscar Health, Inc. (OSCR)vs › | $8.02B | -3.14% | -1.08% | -5.02% | -19.32% |
| Chemed Corporation (CHE)vs › | $6.63B | 15.93% | 16.80% | 17.55% | 18.41% |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.47B | 6.82% | 6.08% | -0.44% | -8.67% |
| Insulet Corp. (PODD)vs › | $9.12B | 21.67% | 20.24% | 16.36% | 15.66% |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.61B | -395.82% | -536.17% | -471.62% | -471.62% |
| Henry Schein, Inc. (HSIC)vs › | $9.67B | 8.11% | 8.11% | 8.28% | 8.19% |
| CRISPR Therapeutics AG (CRSP)vs › | $5.35B | -15636.44% | -8457.23% | -41454.98% | -35632.55% |
| Doximity, Inc. (DOCS)vs › | $5.22B | 35.56% | 38.69% | 36.58% | 34.55% |
| Molina Healthcare, Inc. (MOH)vs › | $9.89B | 2.15% | 3.41% | 4.20% | 4.49% |
Gross Margin
84.5%
EBITDA Margin
-92.1%
Operating Margin
-92.9%
Net Margin
15.2%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | 19.50% |
| 2026-03-31 | 18.23% |
| 2025-12-31 | 16.68% |
| 2025-09-30 | -3.59% |
| 2025-06-30 | -416.49% |
| 2025-03-31 | 11.01% |
| 2024-12-31 | 19.00% |
| 2024-09-30 | -3.21% |
| 2024-06-30 | -18.92% |
| 2024-03-31 | -37.25% |
| 2023-12-31 | -37.28% |
| 2023-09-30 | -27.31% |
| 2023-06-30 | -53.03% |
